Generation bio reports business highlights and second quarter 2021 financial results

Cambridge, mass., aug. 11, 2021 (globe newswire) -- generation bio co. (nasdaq: gbio), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported recent business highlights and second quarter 2021 financial results.

GBIO Ratings Summary

GBIO Quant Ranking